Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Microdispersed Oxidized Cellulose as a novel potential substance with hypolipidemic properties

G. Jamborová, N. Pospíšilová, V. Semecký, R Hyšpler, A. Tichá, K. Pospěchová, D. Solichová, M. Maxová, J. Briestenský, K.J. Real, P. Nachtigal

. 2008 ; 24 (11-12) : 1174-1181.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11006335
E-zdroje Online

NLK ProQuest Central od 2003-01-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest) od 2003-01-01 do Před 2 měsíci
Health & Medicine (ProQuest) od 2003-01-01 do Před 2 měsíci
Health Management Database (ProQuest) od 2003-01-01 do Před 2 měsíci
Public Health Database (ProQuest) od 2003-01-01 do Před 2 měsíci
ScienceDirect (archiv) od 1996-01-01 do 2009-12-31

OBJECTIVE: The aim of this study was to determine whether Microdispersed Oxidized Cellulose (MDOC) possesses a hypolipidemic effect in apolipoprotein-E/low-density lipoprotein receptor double-knockout (ApoE/LDLR-deficient) mice and the possible mechanism of this effect in mice. METHODS: Female ApoE/LDLR-deficient mice subdivided into two groups were fed with a Western-type diet for 8 wk, and the experimental group was supplemented with 5% MDOC for 8 wk. Female C57BL/6J mice were fed an atherogenic diet containing 5% MDOC or pectin for the determination of a possible hypolipidemic mechanism of MDOC action. RESULTS: Biochemical analysis showed that 5% MDOC treatment significantly decreased total cholesterol by 20% (P = 0.0338) and very-LDL cholesterol by 21% (P = 0.0110) and significantly increased the level of high-density lipoprotein cholesterol by 62% (P = 0.0172) when compared with non-treated ApoE/LDLR-deficient mice. The results Association of Official Analytical Chemists method 991.43 revealed that MDOC contains 59.78 +/- 5.0% of fiber. Furthermore, it was demonstrated that administration of MDOC did not affect cholesterol absorption in the small intestine. Using C57BL/6J mice, MDOC and pectin treatments decreased cholesterol content in liver and increased fermentation in the gut in vivo. In vitro experiments confirmed that MDOC is fermentable under conditions mimicking those in the large intestine. CONCLUSION: We demonstrated hypolipidemic effects of MDOC in ApoE/LDLR-deficient mice. Moreover, we propose that MDOC is a hypolipidemic soluble fiber acting probably by increased fermentation and production of short-chain fatty acids in the large intestine in mice. We propose that MDOC might be a possible source of soluble fiber for use in dietary supplements.

000      
02580naa 2200613 a 4500
001      
bmc11006335
003      
CZ-PrNML
005      
20121113124042.0
008      
110401s2008 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Jamborová, Gabriela. $7 _BN003298
245    10
$a Microdispersed Oxidized Cellulose as a novel potential substance with hypolipidemic properties / $c G. Jamborová, N. Pospíšilová, V. Semecký, R Hyšpler, A. Tichá, K. Pospěchová, D. Solichová, M. Maxová, J. Briestenský, K.J. Real, P. Nachtigal
314    __
$a Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
520    9_
$a OBJECTIVE: The aim of this study was to determine whether Microdispersed Oxidized Cellulose (MDOC) possesses a hypolipidemic effect in apolipoprotein-E/low-density lipoprotein receptor double-knockout (ApoE/LDLR-deficient) mice and the possible mechanism of this effect in mice. METHODS: Female ApoE/LDLR-deficient mice subdivided into two groups were fed with a Western-type diet for 8 wk, and the experimental group was supplemented with 5% MDOC for 8 wk. Female C57BL/6J mice were fed an atherogenic diet containing 5% MDOC or pectin for the determination of a possible hypolipidemic mechanism of MDOC action. RESULTS: Biochemical analysis showed that 5% MDOC treatment significantly decreased total cholesterol by 20% (P = 0.0338) and very-LDL cholesterol by 21% (P = 0.0110) and significantly increased the level of high-density lipoprotein cholesterol by 62% (P = 0.0172) when compared with non-treated ApoE/LDLR-deficient mice. The results Association of Official Analytical Chemists method 991.43 revealed that MDOC contains 59.78 +/- 5.0% of fiber. Furthermore, it was demonstrated that administration of MDOC did not affect cholesterol absorption in the small intestine. Using C57BL/6J mice, MDOC and pectin treatments decreased cholesterol content in liver and increased fermentation in the gut in vivo. In vitro experiments confirmed that MDOC is fermentable under conditions mimicking those in the large intestine. CONCLUSION: We demonstrated hypolipidemic effects of MDOC in ApoE/LDLR-deficient mice. Moreover, we propose that MDOC is a hypolipidemic soluble fiber acting probably by increased fermentation and production of short-chain fatty acids in the large intestine in mice. We propose that MDOC might be a possible source of soluble fiber for use in dietary supplements.
590    __
$a bohemika - dle Pubmed
650    _2
$a zvířata $7 D000818
650    _2
$a apolipoproteiny E $x genetika $x nedostatek $7 D001057
650    _2
$a celulosa oxidovaná $x farmakologie $7 D002483
650    _2
$a cholesterol $x krev $7 D002784
650    _2
$a HDL-cholesterol $x krev $7 D008076
650    _2
$a VLDL-cholesterol $x krev $7 D015243
650    _2
$a potravní vláknina $x aplikace a dávkování $x farmakologie $7 D004043
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a kyseliny mastné těkavé $x analýza $7 D005232
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fermentace $7 D005285
650    _2
$a hypolipidemika $x farmakologie $7 D000960
650    _2
$a intestinální absorpce $x fyziologie $x účinky léků $7 D007408
650    _2
$a tlusté střevo $x metabolismus $7 D007420
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a náhodné rozdělení $7 D011897
650    _2
$a receptory LDL $x genetika $x nedostatek $7 D011973
650    _2
$a výsledek terapie $7 D016896
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pospíšilová, Naďa $7 xx0095413
700    1_
$a Semecký, Vladimír, $d 1943- $7 nlk19990073843
700    1_
$a Hyšpler, Radomír, $d 1972- $7 nlk20040155091
700    1_
$a Tichá, Alena, $d 1976- $7 xx0076494
700    1_
$a Pospěchová, Kateřina $7 xx0104147
700    1_
$a Solichová, Dagmar $7 xx0060526
700    1#
$a Maxová, Martina. $7 _BN003292
700    1_
$a Briestenský, Jiří $7 xx0103976
700    1_
$a Real, Keith J
700    1_
$a Nachtigal, Petr $7 uk2009304471
773    0_
$t Nutrition $g Roč. 24, č. 11-12 (2008), s. 1174-1181 $x 0899-9007 $w MED00003566
910    __
$a ABA008 $b x $y 2
990    __
$a 20110414103643 $b ABA008
991    __
$a 20121113124057 $b ABA008
999    __
$a ok $b bmc $g 833937 $s 698432
BAS    __
$a 3
BMC    __
$a 2008 $b 24 $c 11-12 $d 1174-1181 $i 0899-9007 $m Nutrition $n Nutrition $x MED00003566
LZP    __
$a 2011-1B09/jjme

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...